Correlation Between Pfizer and ATyr Pharma,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and ATyr Pharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ATyr Pharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and aTyr Pharma,, you can compare the effects of market volatilities on Pfizer and ATyr Pharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ATyr Pharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ATyr Pharma,.

Diversification Opportunities for Pfizer and ATyr Pharma,

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and ATyr is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and aTyr Pharma, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on aTyr Pharma, and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ATyr Pharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of aTyr Pharma, has no effect on the direction of Pfizer i.e., Pfizer and ATyr Pharma, go up and down completely randomly.

Pair Corralation between Pfizer and ATyr Pharma,

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.4 times more return on investment than ATyr Pharma,. However, Pfizer Inc is 2.51 times less risky than ATyr Pharma,. It trades about -0.07 of its potential returns per unit of risk. aTyr Pharma, is currently generating about -0.13 per unit of risk. If you would invest  2,619  in Pfizer Inc on September 13, 2024 and sell it today you would lose (82.00) from holding Pfizer Inc or give up 3.13% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  aTyr Pharma,

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
aTyr Pharma, 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in aTyr Pharma, are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, ATyr Pharma, reported solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and ATyr Pharma, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and ATyr Pharma,

The main advantage of trading using opposite Pfizer and ATyr Pharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ATyr Pharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma, will offset losses from the drop in ATyr Pharma,'s long position.
The idea behind Pfizer Inc and aTyr Pharma, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum